With federal research funding imperiled by brutal cuts under the Trump administration, biomedical graduate programs nationwide are making tough decisions that will scale back the next generation of scientists.
On Wednesday, news broke that UMass Chan Medical School—a public school in the University of Massachusetts system—has rescinded all offers of admission to biomedical graduate students for the 2025–2026 school year. That means an entire class of future scientists has been wiped out. Those who were initially accepted to the program can try to join again in a future cycle under a priority consideration that won’t require them to reapply, according to a letter sent to a previously admitted student that was shared on social media.
In a statement provided to NBC10 Boston, a spokesperson for the school confirmed that several dozen applicants had their acceptance offers rescinded. “With uncertainties related to the funding of biomedical research in this country, this difficult decision was made to ensure that our current students’ progress is not disrupted by the funding cuts and that we avoid matriculating students who may not have robust opportunities for dissertation research,” the statement reads.